In line with our in vitro observations, we found a selective down-modulation of IL-1β levels in the course of endotoxin sepsis whereas other pro-inflammatory cytokines remained unaffected by the treatment (Fig. 5a–c). The gene discussed is IL1B; the disease is Sepsis.